Company / Operating Cash Flow per Share
Annovis Bio, Inc. Operating Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.81
FY2025
5-year range
-$3.80 / -$0.58
FY2021-FY2025
Trend
+52.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 6 years, ranging from $-3.80 in FY2024 to $-0.58 in FY2021.
Based on SEC 10-K filings.
-1.81 in FY2025.
Improved from $-2.12 to $-1.81 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 52.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2021.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.81 | +52.3% |
| FY2024 | -$3.80 | -79.2% |
| FY2023 | -$2.12 | +0.8% |
| FY2022 | -$2.14 | -270.9% |
| FY2021 | -$0.58 | +65.8% |
| FY2020 | -$1.69 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026